hrp0095fc1.6 | Thyroid | ESPE2022

Thyroid complications after haemopoietic stem cell transplantation in children and adolescents

Fotiadou Anatoli , Vlachopapadopoulou Elpis-Athina , Paisiou Anna , Goussetis Eugenios , Kafetzi Maria , Karagianni Vilelmini , Peristeri Ioulia , Michalacos Stefanos

Background: Haemopoietic stem cell transplantation (HSCT) has become the treatment of choice for many inherited and acquired pediatric disorders. Cure is not without consequences, and HSCT survivors are at risk of early mortality and developing endocrine complications. Thyroid is highly susceptible to damage from the conditioning therapy for HSCT. The aim of this study is to evaluate the percentage and risk factors of thyroid dysfunction and risk factors of it...

hrp0095p2-46 | Bone, Growth Plate and Mineral Metabolism | ESPE2022

Successful treatment with zoledronic acid of a 13-year-old boy with corticosteroid-induced osteoporosis after hematopoietic stem cell transplantation

Athina Vlachopapadopoulou Elpis , Bonataki Myrto , Doulgeraki Artemis , Polyzois Giorgos , Paisiou Anna , Goussetis Eugenios , Peristeri Ioulia , Michalacos Stefanos

Background: Allogeneic hematopoietic stem cell transplantation (HSCT) has emerged as an increasingly successful option to cure a variety of malignant disorders in children. Children benefit from improved survival; however, HSCT is associated with numerous acute and long-term toxicities. Osteoporosis is a well described, late effect of allogeneic HSCT, associated with corticosteroid treatment and patients exposed to cumulative doses >9000 mg/m2 of prednisone...